Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 85 to 95 of 95 entries
Sorted by: Best Match Show Resources per page
Physicians' Recognition and Management of Kidney Disease: A Randomized Vignette Study Evaluating the Impact of the KDIGO 2012 CKD Classification System.

Kidney medicine

Hallan SI, Rifkin DE, Potok OA, Langlo KA, Dekker FW, Ix JH.
PMID: 32734245
Kidney Med. 2020 Feb 22;2(3):258-266. doi: 10.1016/j.xkme.2019.12.008. eCollection 2020.

RATIONALE & OBJECTIVE: The Kidney Disease Outcome Quality Initiative (KDOQI) and Kidney Disease: Improving Global Outcomes (KDIGO) chronic kidney disease (CKD) classification systems published in 2002 and 2012, respectively, are recommended worldwide and based on strong epidemiologic data. However,...

Cite
Hallan SI, Rifkin DE, Potok OA, et al. Physicians' Recognition and Management of Kidney Disease: A Randomized Vignette Study Evaluating the Impact of the KDIGO 2012 CKD Classification System. Kidney Med. 2020;2(3):258-266doi: 10.1016/j.xkme.2019.12.008.
Hallan, S. I., Rifkin, D. E., Potok, O. A., Langlo, K. A., Dekker, F. W., & Ix, J. H. (2020). Physicians' Recognition and Management of Kidney Disease: A Randomized Vignette Study Evaluating the Impact of the KDIGO 2012 CKD Classification System. Kidney medicine, 2(3), 258-266. https://doi.org/10.1016/j.xkme.2019.12.008
Hallan, Stein I, et al. "Physicians' Recognition and Management of Kidney Disease: A Randomized Vignette Study Evaluating the Impact of the KDIGO 2012 CKD Classification System." Kidney medicine vol. 2,3 (2020): 258-266. doi: https://doi.org/10.1016/j.xkme.2019.12.008
Hallan SI, Rifkin DE, Potok OA, Langlo KA, Dekker FW, Ix JH. Physicians' Recognition and Management of Kidney Disease: A Randomized Vignette Study Evaluating the Impact of the KDIGO 2012 CKD Classification System. Kidney Med. 2020 Feb 22;2(3):258-266. doi: 10.1016/j.xkme.2019.12.008. eCollection 2020. PMID: 32734245; PMCID: PMC7380357.
Copy Download .nbib Format: NLM
Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA).

The British journal of ophthalmology

Henry CR, Shah M, Barakat MR, Dayani P, Wang RC, Khurana RN, Rifkin L, Yeh S, Hall C, Ciulla T.
PMID: 33547034
Br J Ophthalmol. 2021 Feb 05; doi: 10.1136/bjophthalmol-2020-318019. Epub 2021 Feb 05.

PURPOSE: To evaluate local and systemic safety of suprachoroidal (SC) triamcinolone acetonide injectable suspension (CLS-TA) injections in subjects with non-infectious uveitis (NIU).DESIGN: Open-label, prospective multicentre safety study.PARTICIPANTS: Thirty-eight subjects with NIU, with and without macular oedema (MO).METHODS: Treatment consisted...

Cite
Henry CR, Shah M, Barakat MR, et al. Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA). Br J Ophthalmol. 2021;doi: 10.1136/bjophthalmol-2020-318019.
Henry, C. R., Shah, M., Barakat, M. R., Dayani, P., Wang, R. C., Khurana, R. N., Rifkin, L., Yeh, S., Hall, C., & Ciulla, T. (2021). Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA). The British journal of ophthalmology, . https://doi.org/10.1136/bjophthalmol-2020-318019
Henry, Christopher Ryan, et al. "Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)." The British journal of ophthalmology vol. (2021). doi: https://doi.org/10.1136/bjophthalmol-2020-318019
Henry CR, Shah M, Barakat MR, Dayani P, Wang RC, Khurana RN, Rifkin L, Yeh S, Hall C, Ciulla T. Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA). Br J Ophthalmol. 2021 Feb 05; doi: 10.1136/bjophthalmol-2020-318019. Epub 2021 Feb 05. PMID: 33547034.
Copy Download .nbib Format: NLM
Perceptions of Telehealth vs In-Person Visits Among Older Adults With Advanced Kidney Disease, Care Partners, and Clinicians.

JAMA network open

Ladin K, Porteny T, Perugini JM, Gonzales KM, Aufort KE, Levine SK, Wong JB, Isakova T, Rifkin D, Gordon EJ, Rossi A, Koch-Weser S, Weiner DE.
PMID: 34870680
JAMA Netw Open. 2021 Dec 01;4(12):e2137193. doi: 10.1001/jamanetworkopen.2021.37193.

IMPORTANCE: Telehealth has been posited as a cost-effective means for improving access to care for persons with chronic conditions, including kidney disease. Perceptions of telehealth among older patients with chronic illness, their care partners, and clinicians are largely unknown...

Cite
Ladin K, Porteny T, Perugini JM, et al. Perceptions of Telehealth vs In-Person Visits Among Older Adults With Advanced Kidney Disease, Care Partners, and Clinicians. JAMA Netw Open. 2021;4(12):e2137193doi: 10.1001/jamanetworkopen.2021.37193.
Ladin, K., Porteny, T., Perugini, J. M., Gonzales, K. M., Aufort, K. E., Levine, S. K., Wong, J. B., Isakova, T., Rifkin, D., Gordon, E. J., Rossi, A., Koch-Weser, S., & Weiner, D. E. (2021). Perceptions of Telehealth vs In-Person Visits Among Older Adults With Advanced Kidney Disease, Care Partners, and Clinicians. JAMA network open, 4(12), e2137193. https://doi.org/10.1001/jamanetworkopen.2021.37193
Ladin, Keren, et al. "Perceptions of Telehealth vs In-Person Visits Among Older Adults With Advanced Kidney Disease, Care Partners, and Clinicians." JAMA network open vol. 4,12 (2021): e2137193. doi: https://doi.org/10.1001/jamanetworkopen.2021.37193
Ladin K, Porteny T, Perugini JM, Gonzales KM, Aufort KE, Levine SK, Wong JB, Isakova T, Rifkin D, Gordon EJ, Rossi A, Koch-Weser S, Weiner DE. Perceptions of Telehealth vs In-Person Visits Among Older Adults With Advanced Kidney Disease, Care Partners, and Clinicians. JAMA Netw Open. 2021 Dec 01;4(12):e2137193. doi: 10.1001/jamanetworkopen.2021.37193. PMID: 34870680; PMCID: PMC8649833.
Copy Download .nbib Format: NLM
Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series.

Blood purification

Rifkin BS, Stewart IJ.
PMID: 34261058
Blood Purif. 2021 Jul 14;1-4. doi: 10.1159/000517430. Epub 2021 Jul 14.

There is an urgent need for therapeutic interventions to alter the course of critically ill coronavirus disease 2019 (CO-VID-19) patients. We report our experience with the Seraph-100 Microbind Affinity Blood Filter (Seraph-100) in 4 patients with COVID-19 early in...

Cite
Rifkin BS, Stewart IJ. Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series. Blood Purif. 2021;1-4doi: 10.1159/000517430.
Rifkin, B. S., & Stewart, I. J. (2021). Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series. Blood purification, 1-4. https://doi.org/10.1159/000517430
Rifkin, Brian S, and Stewart, Ian J. "Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series." Blood purification vol. (2021): 1-4. doi: https://doi.org/10.1159/000517430
Rifkin BS, Stewart IJ. Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series. Blood Purif. 2021 Jul 14;1-4. doi: 10.1159/000517430. Epub 2021 Jul 14. PMID: 34261058; PMCID: PMC8339049.
Copy Download .nbib Format: NLM
Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series.

Blood purification

Rifkin BS, Stewart IJ.
PMID: 34261058
Blood Purif. 2021 Jul 14;1-4. doi: 10.1159/000517430. Epub 2021 Jul 14.

There is an urgent need for therapeutic interventions to alter the course of critically ill coronavirus disease 2019 (CO-VID-19) patients. We report our experience with the Seraph-100 Microbind Affinity Blood Filter (Seraph-100) in 4 patients with COVID-19 early in...

Cite
Rifkin BS, Stewart IJ. Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series. Blood Purif. 2021;1-4doi: 10.1159/000517430.
Rifkin, B. S., & Stewart, I. J. (2021). Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series. Blood purification, 1-4. https://doi.org/10.1159/000517430
Rifkin, Brian S, and Stewart, Ian J. "Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series." Blood purification vol. (2021): 1-4. doi: https://doi.org/10.1159/000517430
Rifkin BS, Stewart IJ. Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series. Blood Purif. 2021 Jul 14;1-4. doi: 10.1159/000517430. Epub 2021 Jul 14. PMID: 34261058; PMCID: PMC8339049.
Copy Download .nbib Format: NLM
The role of LTBPs in TGF beta signaling.

Developmental dynamics : an official publication of the American Association of Anatomists

Rifkin D, Sachan N, Singh K, Sauber E, Tellides G, Ramirez F.
PMID: 33742701
Dev Dyn. 2022 Jan;251(1):95-104. doi: 10.1002/dvdy.331. Epub 2021 Mar 25.

The purpose of this review is to discuss the transforming growth factor beta (TGFB) binding proteins (LTBP) with respect to their participation in the activity of TGFB. We first describe pertinent aspects of the biology and cell function of...

Cite
Rifkin D, Sachan N, Singh K, et al. The role of LTBPs in TGF beta signaling. Dev Dyn. 2021;251(1):95-104doi: 10.1002/dvdy.331.
Rifkin, D., Sachan, N., Singh, K., Sauber, E., Tellides, G., & Ramirez, F. (2022). The role of LTBPs in TGF beta signaling. Developmental dynamics : an official publication of the American Association of Anatomists, 251(1), 95-104. https://doi.org/10.1002/dvdy.331
Rifkin, Daniel, et al. "The role of LTBPs in TGF beta signaling." Developmental dynamics : an official publication of the American Association of Anatomists vol. 251,1 (2022): 95-104. doi: https://doi.org/10.1002/dvdy.331
Rifkin D, Sachan N, Singh K, Sauber E, Tellides G, Ramirez F. The role of LTBPs in TGF beta signaling. Dev Dyn. 2022 Jan;251(1):95-104. doi: 10.1002/dvdy.331. Epub 2021 Mar 25. PMID: 33742701.
Copy Download .nbib Format: NLM
Evaluation of a Polyurethane Platform for Delivery of Nanohydroxyapatite and Decellularized Bone Particles in a Porous Three-Dimensional Scaffold.

ACS applied bio materials

Bow A, Newby S, Rifkin R, Jackson BK, Matavosian A, Griffin C, King W, Alghazali K, Mhannawee A, Berryhill SB, Morello R, Hecht S, Biris AS, Anderson DE, Bourdo SE, Dhar M.
PMID: 35030672
ACS Appl Bio Mater. 2019 May 20;2(5):1815-1829. doi: 10.1021/acsabm.8b00670. Epub 2019 Apr 08.

The complex dynamic nature of bone tissue presents a unique challenge for developing optimal biomaterials within the field of bone tissue engineering. Materials based on biological and physiological characteristics of natural bone have shown promise for inducing and promoting...

Cite
Bow A, Newby S, Rifkin R, et al. Evaluation of a Polyurethane Platform for Delivery of Nanohydroxyapatite and Decellularized Bone Particles in a Porous Three-Dimensional Scaffold. ACS Appl Bio Mater. 2019;2(5):1815-1829doi: 10.1021/acsabm.8b00670.
Bow, A., Newby, S., Rifkin, R., Jackson, B. K., Matavosian, A., Griffin, C., King, W., Alghazali, K., Mhannawee, A., Berryhill, S. B., Morello, R., Hecht, S., Biris, A. S., Anderson, D. E., Bourdo, S. E., & Dhar, M. (2019). Evaluation of a Polyurethane Platform for Delivery of Nanohydroxyapatite and Decellularized Bone Particles in a Porous Three-Dimensional Scaffold. ACS applied bio materials, 2(5), 1815-1829. https://doi.org/10.1021/acsabm.8b00670
Bow, Austin, et al. "Evaluation of a Polyurethane Platform for Delivery of Nanohydroxyapatite and Decellularized Bone Particles in a Porous Three-Dimensional Scaffold." ACS applied bio materials vol. 2,5 (2019): 1815-1829. doi: https://doi.org/10.1021/acsabm.8b00670
Bow A, Newby S, Rifkin R, Jackson BK, Matavosian A, Griffin C, King W, Alghazali K, Mhannawee A, Berryhill SB, Morello R, Hecht S, Biris AS, Anderson DE, Bourdo SE, Dhar M. Evaluation of a Polyurethane Platform for Delivery of Nanohydroxyapatite and Decellularized Bone Particles in a Porous Three-Dimensional Scaffold. ACS Appl Bio Mater. 2019 May 20;2(5):1815-1829. doi: 10.1021/acsabm.8b00670. Epub 2019 Apr 08. PMID: 35030672.
Copy Download .nbib Format: NLM
Tiny, ornamented eggs and eggshell from the Upper Cretaceous of Utah represent a new ootaxon with theropod affinities.

Scientific reports

Oser SE, Chin K, Sertich JJW, Varricchio DJ, Choi S, Rifkin J.
PMID: 33976315
Sci Rep. 2021 May 11;11(1):10021. doi: 10.1038/s41598-021-89472-1.

A new Cretaceous ootaxon (eggshell type) from the Kaiparowits Formation of Grand Staircase-Escalante National Monument is among a growing number of very small eggs described from the Mesozoic. Analyses of two partial eggs (~ 17.7 mm in diameter) and...

Cite
Oser SE, Chin K, Sertich JJW, et al. Tiny, ornamented eggs and eggshell from the Upper Cretaceous of Utah represent a new ootaxon with theropod affinities. Sci Rep. 2021;11(1):10021doi: 10.1038/s41598-021-89472-1.
Oser, S. E., Chin, K., Sertich, J. J. W., Varricchio, D. J., Choi, S., & Rifkin, J. (2021). Tiny, ornamented eggs and eggshell from the Upper Cretaceous of Utah represent a new ootaxon with theropod affinities. Scientific reports, 11(1), 10021. https://doi.org/10.1038/s41598-021-89472-1
Oser, Sara E, et al. "Tiny, ornamented eggs and eggshell from the Upper Cretaceous of Utah represent a new ootaxon with theropod affinities." Scientific reports vol. 11,1 (2021): 10021. doi: https://doi.org/10.1038/s41598-021-89472-1
Oser SE, Chin K, Sertich JJW, Varricchio DJ, Choi S, Rifkin J. Tiny, ornamented eggs and eggshell from the Upper Cretaceous of Utah represent a new ootaxon with theropod affinities. Sci Rep. 2021 May 11;11(1):10021. doi: 10.1038/s41598-021-89472-1. PMID: 33976315; PMCID: PMC8113451.
Copy Download .nbib Format: NLM
Self-reported Metabolic Risk Factor Associations with Adenomatous, Sessile Serrated, and Synchronous Adenomatous and Sessile Serrated Polyps.

Cancer prevention research (Philadelphia, Pa.)

Santiago CN, Rifkin S, Drewes J, Mullin G, Spence E, Hylind LM, Gills JJ, Kafonek D, Cromwell DM, La Luna L, Giardello F, Sears CL.
PMID: 33947705
Cancer Prev Res (Phila). 2021 Jul;14(7):697-708. doi: 10.1158/1940-6207.CAPR-20-0664. Epub 2021 May 04.

Studies have found a positive association between metabolic risk factors, such as obesity and diabetes, and adenomatous polyps (AP). However, fewer studies have assessed the association between sessile serrated polyps (SSP) or synchronous diagnosis of APs and SSPs (synch...

Cite
Santiago CN, Rifkin S, Drewes J, et al. Self-reported Metabolic Risk Factor Associations with Adenomatous, Sessile Serrated, and Synchronous Adenomatous and Sessile Serrated Polyps. Cancer Prev Res (Phila). 2021;14(7):697-708doi: 10.1158/1940-6207.CAPR-20-0664.
Santiago, C. N., Rifkin, S., Drewes, J., Mullin, G., Spence, E., Hylind, L. M., Gills, J. J., Kafonek, D., Cromwell, D. M., La Luna, L., Giardello, F., Sears, C. L. (2021). Self-reported Metabolic Risk Factor Associations with Adenomatous, Sessile Serrated, and Synchronous Adenomatous and Sessile Serrated Polyps. Cancer prevention research (Philadelphia, Pa.), 14(7), 697-708. https://doi.org/10.1158/1940-6207.CAPR-20-0664
Santiago, Celina N, et al. "Self-reported Metabolic Risk Factor Associations with Adenomatous, Sessile Serrated, and Synchronous Adenomatous and Sessile Serrated Polyps." Cancer prevention research (Philadelphia, Pa.) vol. 14,7 (2021): 697-708. doi: https://doi.org/10.1158/1940-6207.CAPR-20-0664
Santiago CN, Rifkin S, Drewes J, Mullin G, Spence E, Hylind LM, Gills JJ, Kafonek D, Cromwell DM, La Luna L, Giardello F, Sears CL. Self-reported Metabolic Risk Factor Associations with Adenomatous, Sessile Serrated, and Synchronous Adenomatous and Sessile Serrated Polyps. Cancer Prev Res (Phila). 2021 Jul;14(7):697-708. doi: 10.1158/1940-6207.CAPR-20-0664. Epub 2021 May 04. PMID: 33947705; PMCID: PMC8295232.
Copy Download .nbib Format: NLM
A New Score for Quantifying Adherence to a Cancer-Preventive Mediterranean Diet.

Nutrition and cancer

Djuric Z, Rifkin S.
PMID: 33840312
Nutr Cancer. 2021 Apr 10;1-13. doi: 10.1080/01635581.2021.1909738. Epub 2021 Apr 10.

Herein a Mediterranean Cancer Preventive Diet Score (MCAP Score) is proposed to quantify adherence to both traditional Mediterranean fat intakes and the current dietary recommendations for cancer prevention. The scoring uses research-backed cutoff values, unlike other scores that are...

Cite
Djuric Z, Rifkin S. A New Score for Quantifying Adherence to a Cancer-Preventive Mediterranean Diet. Nutr Cancer. 2021;1-13doi: 10.1080/01635581.2021.1909738.
Djuric, Z., & Rifkin, S. (2021). A New Score for Quantifying Adherence to a Cancer-Preventive Mediterranean Diet. Nutrition and cancer, 1-13. https://doi.org/10.1080/01635581.2021.1909738
Djuric, Zora, and Rifkin, Samara. "A New Score for Quantifying Adherence to a Cancer-Preventive Mediterranean Diet." Nutrition and cancer vol. (2021): 1-13. doi: https://doi.org/10.1080/01635581.2021.1909738
Djuric Z, Rifkin S. A New Score for Quantifying Adherence to a Cancer-Preventive Mediterranean Diet. Nutr Cancer. 2021 Apr 10;1-13. doi: 10.1080/01635581.2021.1909738. Epub 2021 Apr 10. PMID: 33840312.
Copy Download .nbib Format: NLM
A New Score for Quantifying Adherence to a Cancer-Preventive Mediterranean Diet.

Nutrition and cancer

Djuric Z, Rifkin S.
PMID: 33840312
Nutr Cancer. 2021 Apr 10;1-13. doi: 10.1080/01635581.2021.1909738. Epub 2021 Apr 10.

Herein a Mediterranean Cancer Preventive Diet Score (MCAP Score) is proposed to quantify adherence to both traditional Mediterranean fat intakes and the current dietary recommendations for cancer prevention. The scoring uses research-backed cutoff values, unlike other scores that are...

Cite
Djuric Z, Rifkin S. A New Score for Quantifying Adherence to a Cancer-Preventive Mediterranean Diet. Nutr Cancer. 2021;1-13doi: 10.1080/01635581.2021.1909738.
Djuric, Z., & Rifkin, S. (2021). A New Score for Quantifying Adherence to a Cancer-Preventive Mediterranean Diet. Nutrition and cancer, 1-13. https://doi.org/10.1080/01635581.2021.1909738
Djuric, Zora, and Rifkin, Samara. "A New Score for Quantifying Adherence to a Cancer-Preventive Mediterranean Diet." Nutrition and cancer vol. (2021): 1-13. doi: https://doi.org/10.1080/01635581.2021.1909738
Djuric Z, Rifkin S. A New Score for Quantifying Adherence to a Cancer-Preventive Mediterranean Diet. Nutr Cancer. 2021 Apr 10;1-13. doi: 10.1080/01635581.2021.1909738. Epub 2021 Apr 10. PMID: 33840312; PMCID: PMC8693912.
Copy Download .nbib Format: NLM
Showing 85 to 95 of 95 entries